Electrostatic charge-based hydrogel bioprinting for fabricating ultra-thin multicellular biomimetic tissues
This technology uses electrical charges to shrink bioprinted hydrogels, allowing the creation of complex, natural-like tissues just 100 microns thick with multiple cell types for improved tissue regeneration.
Background
The field of tissue engineering focuses on creating living tissue substitutes to repair or replace damaged tissues, develop laboratory models for drug testing, and improve surgical outcomes. Many native tissues, such as the thin periosteum layer covering bone or specialized epithelial sheets, measure only tens to a few hundred microns thick. Reproducing these delicate structures in vitro is essential for mimicking natural function, ensuring proper cell behavior, and facilitating integration with host tissue. However, achieving consistent thickness and structural fidelity at this scale remains a major challenge in regenerative medicine and biofabrication.
Conventional bioprinting and scaffold-based approaches often rely on depositing relatively thick hydrogel layers or stacking cell sheets, leading to constructs that exceed the target thickness by several fold. This limits nutrient diffusion, reduces cell viability in inner regions, and hinders the recreation of distinct microenvironments needed for multiple cell types. Additionally, most methods lack the precision to pattern cells at sub-200 micron resolutions, resulting in bulky tissues that fail to replicate the fine architecture of natural membranes. Mechanical weaknesses and long fabrication times further complicate efforts to scale these techniques for clinical or research applications.
Technology
This system for fabricating thin membranous tissues manipulates electrical charges between two biomaterials to trigger a controlled shrinking effect in bioprinted water-rich gels. Adjusting the charges enhances detail and sharpness of printed patterns, enabling membranes as thin as about 100 microns, similar to natural layers like the periosteum. It supports placement of different cell types within a single membrane, creating complex structures that reflect the multi-layered makeup of living tissues. The approach integrates shrinking directly into the printing workflow, producing stable, high-resolution sheets without extra processing and opening new possibilities for repairing or replacing damaged tissue.
This technique stands out by overcoming the thickness and uniformity limits that have long restricted bioprinted tissues. Traditional hydrogel printing often yields membranes several times thicker, losing fine details and realistic cell arrangements. In contrast, charge-driven shrinking enables finer control over final dimensions without harming cell viability or material integrity. As a result, researchers can replicate delicate tissue interfaces and create more accurate models for regeneration studies or clinical grafts. The gentle, electrically guided process also reduces stress on living cells, making it a promising platform for next-generation tissue engineering applications.
Benefits
- Enables fabrication of ultra-thin tissues (~100 μm) with enhanced resolution
- Allows generation of complex, multicellular tissue anatomies
- Mimics natural tissue structures for improved biomimicry
- Advances tissue regeneration by overcoming previous fabrication limitations
Applications
- Periosteum graft implants
- Organ-on-chip membrane platforms
- Drug screening tissue models
- Wound healing membranes
- Cosmetic testing skin models
Additional info
An electrostatic technique drives controlled shrinkage in bioprinted hydrogels by manipulating charge interactions between two biomaterials, producing membranous layers near 100 µm thickness. Precise voltage adjustment sharpens printing resolution and embeds multiple cell types within complex, tissue-mimetic architectures (e.g., periosteum). This approach overcomes previous limits on minimal thickness and structural fidelity, enabling advanced regenerative therapies with ultra-thin, biomimetic tissue constructs.
Publication
“4D Bioprinting via Molecular Network Contraction for Membranous Tissue Fabrication.” McLoughlin ST, McKenna AR, Fisher JP. Adv Healthc Mater. 2023 Oct;12(27)